Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 19Tumor-Agnostic 6Sarcoma 6Gastrointestinal 3Genitourinary 2NET 1Lymphoid 1Endocrine 1Dermatologic 1

Conditions

Lymphoma 16Central Nervous System Neoplasms 9Lymphoma, Follicular 5Astrocytoma 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Glioblastoma 4Lymphoma, Non-Hodgkin 3Glioma 3Recurrence 2Oligodendroglioma 2Neuroectodermal Tumors, Primitive 2Leukemia, Myeloid, Acute 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia 2Gliosarcoma 2Glioma, Subependymal 2Ependymoma 2Burkitt Lymphoma 2Brain Neoplasms 2Blast Crisis 2Triple Negative Breast Neoplasms 1Sezary Syndrome 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pinealoma 1Ovarian Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Mycosis Fungoides 1Meningioma 1Medulloblastoma 1

Interventions

Cyclophosphamide 35Rituximab 33venetoclax 24ibrutinib 14Vincristine 14Prednisone 14Doxorubicin 14Gemcitabine 13pembrolizumab 12fludarabine 12Bendamustine Hydrochloride 11Etoposide 10obinutuzumab 9Filgrastim 9Dexamethasone 9Bortezomib 9fludarabine phosphate 8Mycophenolic Acid 8Drug Therapy 8ofatumumab 7Whole-Body Irradiation 7Sirolimus 7Peripheral Blood Stem Cell Transplantation 7Methotrexate 7Busulfan 7Therapeutics 6Radiotherapy 6Mesna 6Lenalidomide 6Ipilimumab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Temozolomide × Lymphoid × Clear all
NCT06208657 2026-01-28

Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer

Australian & New Zealand Children's Haematology/Oncology Group

Phase 1/2 Recruiting
90 enrolled
CNSLymphoid

Lymphoma, Neoplasms, Recurrence, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡